-
Malcolm,
J.
Moore,
J.
Andersen,
M.
Green,
M.
Rothenberg,
M.
Modiano,
M.
Cripps,
Russell,
K.
Portenoy,
A.
Storniolo,
P.
Tarassoff,
R.
Nelson,
F.
Dorr,
C.
Stephens,
Daniel,
D.,
Von
Hoff
(1997)
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15 6
-
L.
Geest,
N.
Mohammad,
M.
Besselink,
V.
Lemmens,
J.
Portielje,
Hanneke
Laarhoven,
J.
Wilmink
(2017)
Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer
Cancer Medicine, 6
-
M.
Ilic,
I.
Ilic
(2016)
Epidemiology of pancreatic cancer
World Journal of Gastroenterology, 22
-
A.
Sultana,
Catrin
Smith,
D.
Cunningham,
N.
Starling,
J.
Neoptolemos,
P.
Ghaneh
(2007)
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 18
-
Namrata
Vijayvergia,
E.
Dotan,
K.
Devarajan,
Kamel
Hatahet,
F.
Rahman,
J.
Ricco,
Bianca
Lewis,
Sameer
Gupta,
S.
Cohen
(2015)
Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experience.
Journal of geriatric oncology, 6 6
-
D.
Hoff,
T.
Ervin,
F.
Arena,
E.
Chiorean,
J.
Infante,
M.
Moore,
T.
Seay,
S.
Tjulandin,
W.
Ma,
M.
Saleh,
M.
Harris,
M.
Reni,
S.
Dowden,
D.
Laheru,
N.
Bahary,
R.
Ramanathan,
J.
Tabernero,
M.
Hidalgo,
D.
Goldstein,
E.
Cutsem,
Xinyu
Wei,
J.
Iglesias,
M.
Renschler
(2013)
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
The New England journal of medicine, 369 18
-
C.
Baldini,
A.
Escande,
O.
Bouché,
F.
hajbi,
J.
Volet,
V.
Bourgeois,
T.
Vantroys,
A.
Ploquin,
C.
Desauw,
M.
Hebbar
(2017)
Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysis.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 17 1
-
T.
Golan,
T.
Sella,
O.
Margalit,
U.
Amit,
N.
Halpern,
D.
Aderka,
E.
Shacham-Shmueli,
D.
Urban,
Y.
Lawrence
(2017)
Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993-2013.
Journal of the National Comprehensive Cancer Network : JNCCN, 15 8
-
David
Propper,
I.
Davidenko,
J.
Bridgewater,
L.
Kupčinskas,
A.
Fittipaldo,
C.
Hillenbach,
B.
Klughammer,
M.
Ducreux
(2014)
Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology, 25 7
-
Hongxuan
Tong,
Zhu
Fan,
Biyuan
Liu,
Tao
Lu
(2018)
The benefits of modified FOLFIRINOX for advanced pancreatic cancer and its induced adverse events: a systematic review and meta-analysis
Scientific Reports, 8
-
Daneng
Li,
M.
Capanu,
Kenneth
Yu,
M.
Lowery,
D.
Kelsen,
E.
O’Reilly
(2015)
Treatment, Outcomes, and Clinical Trial Participation in Elderly Patients With Metastatic Pancreas Adenocarcinoma.
Clinical colorectal cancer, 14 4
-
T.
Macarulla,
R.
Pazo-Cid,
C.
Guillén-Ponce,
R.
López,
R.
Vera,
M.
Reboredo,
A.
Martín,
F.
Rivera,
R.
Beveridge,
A.
Casta,
J.
Valadés,
J.
Martinez-Galan,
I.
Ales,
J.
Sastre,
S.
Perea,
M.
Hidalgo
(2019)
Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37 3
-
End-of-life care for people with cancer from ethnic minority groups: a systematic review
-
A.
Berger,
G.
Haag,
M.
Ehmann,
A.
Byl,
D.
Jäger,
C.
Springfeld
(2017)
Palliative chemotherapy for pancreatic adenocarcinoma: a retrospective cohort analysis of efficacy and toxicity of the FOLFIRINOX regimen focusing on the older patient
BMC Gastroenterology, 17
-
A.
Quante,
Chang
Ming,
M.
Rottmann,
J.
Engel,
S.
Boeck,
V.
Heinemann,
C.
Westphalen,
K.
Strauch
(2016)
Projections of cancer incidence and cancer‐related deaths in Germany by 2020 and 2030
Cancer Medicine, 5
-
O.
Hentic,
C.
Dreyer,
V.
Rebours,
M.
Zappa,
P.
Lévy,
E.
Raymond,
P.
Ruszniewski,
P.
Hammel
(2011)
Gemcitabine in elderly patients with advanced pancreatic cancer.
World journal of gastroenterology, 17 30
-
Y.
Nakai,
H.
Isayama,
Takashi
Sasaki,
N.
Sasahira,
T.
Tsujino,
H.
Kogure,
H.
Yagioka,
Y.
Yashima,
O.
Togawa,
T.
Arizumi,
S.
Matsubara,
K.
Hirano,
M.
Tada,
M.
Omata,
K.
Koike
(2011)
Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy.
Critical reviews in oncology/hematology, 78 3
-
M.
LoPresti,
Fritz
Dement,
H.
Gold
(2016)
End-of-Life Care for People With Cancer From Ethnic Minority Groups
American Journal of Hospice and Palliative Medicine®, 33
-
V.
Jesus,
M.
Camandaroba,
M.
Donadio,
A.
Cabral,
T.
Muniz,
Luciana
Leite,
L.
Santana
(2018)
Retrospective comparison of the efficacy and the toxicity of standard and modified FOLFIRINOX regimens in patients with metastatic pancreatic adenocarcinoma.
Journal of gastrointestinal oncology, 9 4
-
P.
Oberstein,
D.
Hershman,
Lauren
Khanna,
J.
Chabot,
B.
Insel,
A.
Neugut
(2013)
Uptake and Patterns of Use of Gemcitabine for Metastatic Pancreatic Cancer: A Population-Based Study
Cancer Investigation, 31
-
A.
Lowenfels,
P.
Maisonneuve
(2005)
Risk factors for pancreatic cancer
Journal of Cellular Biochemistry, 95
-
C.
Chrystoja,
E.
Diamandis,
R.
Brand,
F.
Rückert,
R.
Haun,
R.
Molina
(2013)
Pancreatic cancer.
Clinical chemistry, 59 1
-
T.
Conroy,
F.
Desseigne,
M.
Ychou,
O.
Bouché,
R.
Guimbaud,
Y.
Bécouarn,
A.
Adenis,
J.
Raoul,
S.
Gourgou-Bourgade,
C.
Fouchardière,
J.
Bennouna,
J.
Bachet,
F.
Khemissa-Akouz,
D.
Péré-Vergé,
C.
Delbaldo,
E.
Assenat,
B.
Chauffert,
P.
Michel,
C.
Montoto-Grillot,
M.
Ducreux
(2011)
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
The New England journal of medicine, 364 19
-
L.
Rahib,
Benjamin
Smith,
R.
Aizenberg,
A.
Rosenzweig,
Julie
Fleshman,
L.
Matrisian
(2014)
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Cancer research, 74 11
-
D.
Ahn,
K.
Krishna,
M.
Blazer,
J.
Reardon,
Lai
Wei,
Christina
Wu,
K.
Ciombor,
A.
Noonan,
S.
Mikhail,
T.
Bekaii-Saab
(2017)
A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis
Therapeutic Advances in Medical Oncology, 9
-
F.
Bray,
J.
Ferlay,
I.
Soerjomataram,
R.
Siegel,
Lindsey
Torre,
A.
Jemal
(2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA: A Cancer Journal for Clinicians, 68
-
Aabra
Ahmed,
Jenna
Sitenga,
G.
Aird,
R.
Walters,
P.
Silberstein
(2018)
Chemotherapy use in the elderly for stage IV pancreatic cancer: An NCDB analysis.
Journal of Clinical Oncology, 36
-
Y.
Yamagishi,
H.
Higuchi,
Motoko
Izumiya,
Gen
Sakai,
H.
Iizuka,
Shoko
Nakamura,
M.
Adachi,
S.
Hozawa,
H.
Takaishi,
T.
Hibi
(2010)
Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma
Journal of Gastroenterology, 45
-
Jean-Florian
Guion-Dusserre,
A.
Bertaut,
F.
Ghiringhelli,
J.
Vincent,
V.
Quipourt,
S.
Marilier,
Z.
Tharin,
L.
Bengrine-Lefevre
(2016)
Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy
World Journal of Gastroenterology, 22
-
H.
Wildiers,
P.
Heeren,
M.
Puts,
E.
Topinkova,
M.
Janssen-Heijnen,
M.
Extermann,
C.
Falandry,
A.
Artz,
E.
Brain,
G.
Colloca,
J.
Flamaing,
T.
Karnakis,
C.
Kenis,
R.
Audisio,
S.
Mohile,
L.
Repetto,
B.
Leeuwen,
K.
Milisen,
A.
Hurria
(2014)
International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 32 24
-
R.
Maréchal,
A.
Demols,
F.
Gay,
V.
Maertelaer,
M.
Arvanitaki,
A.
Hendlisz,
J.
Laethem
(2008)
Tolerance and Efficacy of Gemcitabine and Gemcitabine-Based Regimens in Elderly Patients With Advanced Pancreatic Cancer
Pancreas, 36
-
J.
Winter,
A.
Maitra,
C.
Yeo
(2006)
Genetics and pathology of pancreatic cancer.
HPB : the official journal of the International Hepato Pancreato Biliary Association, 8 5
-
Taira
Kuroda,
T.
Kumagi,
T.
Yokota,
Nobuaki
Azemoto,
A.
Hasebe,
H.
Seike,
Mari
Nishiyama,
N.
Inada,
Naozumi
Shibata,
H.
Miyata,
Tomoe
Kawamura,
Yusuke
Imai,
Akiko
Ueno-Toshimori,
Yoshinori
Tanaka,
T.
Terao,
Yoshiki
Imamura,
M.
Koizumi,
Hirofumi
Yamanishi,
Yoshinori
Ohno,
Y.
Hiasa
(2017)
Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients
BMC Gastroenterology, 17
-
E.
Sirri,
F.
Castro,
J.
Kieschke,
L.
Jansen,
K.
Emrich,
A.
Gondos,
B.
Holleczek,
A.
Katalinic,
I.
Urbschat,
C.
Vohmann,
H.
Brenner
(2016)
Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States
Pancreas, 45
-
L.
Hutchins,
J.
Unger,
J.
Crowley,
C.
Coltman,
K.
Albain
(1999)
Underrepresentation of patients 65 years of age or older in cancer-treatment trials.
The New England journal of medicine, 341 27
-
M.
Ghosn,
F.
Farhat,
J.
Kattan,
F.
Younes,
W.
Moukadem,
F.
Nasr,
G.
Chahine
(2007)
FOLFOX-6 Combination as the First-Line Treatment of Locally Advanced and/or Metastatic Pancreatic Cancer
American Journal of Clinical Oncology, 30
-
Taikan
Yamamoto,
Y.
Sunakawa,
Y.
Kubota,
Teppei
Tagawa,
Yasuhiro
Kaga,
T.
Ikusue,
Y.
Uto,
Y.
Kitahara,
H.
Toshima,
K.
Kobayashi,
A.
Hisamatsu,
W.
Ichikawa,
T.
Sekikawa,
K.
Shimada,
Y.
Sasaki
(2016)
Tolerability and clinical outcomes in elderly patients with advanced pancreatic cancer treated with FOLFIRINOX.
Journal of Clinical Oncology, 34